References
- Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2014; 99: 1915-42. doi: 10.1210/jc.2014-1498
- Beilan JA, Lawton A, Hajdenberg J, Rosser CJ. Pheochromocytoma of the urinary bladder: a systematic review of the contemporary literature. BMC Urol 2013; 13: 22. doi: 10.1186/1471-2490-13-22
- Qin J, Zhou G, Chen X. Imaging manifestations of bladder paraganglioma. Ann Palliat Med 2020; 9: 346-51. doi: 10.21037/apm.2020.03.09
- Sharma AP, Bora GS, Mavuduru RS, Panwar VK, Mittal BR, Singh SK. Management of bladder pheochromocytoma by transurethral resection. Asian J Urol 2019; 6: 298-301. doi: 10.1016/j.ajur.2018.05.010
- Tevosian SG, Ghayee HK. Pheochromocytomas and paragangliomas. Endocrinol Metab Clin North Am 2019; 48: 727-50. doi: 10.1016/j.ecl.2019.08.006
- International Agency for Research on Cancer. World Health Organization. WHO classification of tumours of endocrine organs. 4th edition. Lloyd RV, Osamura RY, Klöppel G, Rosai J, editors. Lyon, France: IARC; 2017. p. 78-80.
- Lu H, Male M, Jiang K, Ye Z, Song D, Xia D. Clinical significance of functional and anatomical classifications in paraganglioma of the urinary bladder. Urol Oncol 2019; 37: 354.e9-17. doi: 10.1016/j.urolonc.2019.01.027
- Jain A, Baracco R, Kapur G. Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management. Pediatr Nephrol 2020; 35: 581-94. doi: 10.1007/s00467-018-4181-2
- Henderson SJ, Kearns PJ, Tong CM, Reddy M, Khurgin J, Bickell M, et al. Patients with urinary bladder paragangliomas: a compiled case series from a literature review for clinical management. Urology 2015; 85: e25-9. doi: 10.1016/j.urology.2014.11.006
- Liu F, Xiao H, Wang H, Fang Z, Yu Y, Li Y, et al. [The imaging analysis and diagnosis of the paraganglioma of the urinary bladder]. [Chinese]. Oncoradiology 2020; 29: 181-6. doi: 10.19732/j.cnki.2096-6210.2020.02.018
- Sbardella E, Grossman AB. Pheochromocytoma: an approach to diagnosis. Best Pract Res Clin Endocrinol Metab 2020; 34: 101346. doi: 10.1016/j.beem.2019.101346
- Aygun N, Uludag M. Pheochromocytoma and paraganglioma: from clinical findings to diagnosis. Sisli Etfal Hastan Tip Bul 2020; 54: 271-80. doi: 10.14744/SEMB.2020.14826
- Liang JP, Li HG, Gao LK, Yin L, Yin L, Zhang JW. Bladder paraganglioma: Clinicopathology and magnetic resonance imaging study of five patients. Urol J 2016; 13: 2605-11. doi: 10.22037/uj.v13i2.3140
- Al Johi RS, Seifeldein GS, Moeen AM, Aboulhagag NA, Moussa EM, Hameed DA, et al. Diffusion weighted magnetic resonance imaging in bladder cancer, is it time to replace biopsy? Cent European J Urol 2018; 71: 31-7. doi: 10.5173/ceju.2017.1427
- Wang H, Ye H, Guo A, Wei Z, Zhang X, Zhong Y, et al. B ladder paraganglioma in adults: MR appearance in four patients. Eur J Radiol 2011; 80: e217-20. doi: 10.1016/j.ejrad.2010.09.020
- Fan DG, Wu CL, Huang HJ, Wu L, Lin SY. [Paraganglioma of urinary bladder: a clinicopathological features analysis of 23 cases]. [Chinese]. Zhonghua Bing Li Xue Za Zhi 2020; 49: 311-6. doi: 10.3760/cma.j.cn112151-20190928-00535
- Quist EE, Javadzadeh BM, Johannesen E, Johansson SL, Lele SM, Kozel JA. Malignant paraganglioma of the bladder: a case report and review of the literature. Pathol Res Pract 2015; 211: 183-88. doi: 10.1016/j.prp.2014.10.009
- Raza SA, Jhaveri KS. MR imaging of urinary bladder carcinoma and beyond. Radiol Clin North Am 2012; 50: 1085-110. doi: 10.1016/j.rcl.2012.08.011
- Lenders JWM, Eisenhofer G. Update on modern management of pheochromocytoma and paraganglioma. Endocrinol Metab (Seoul) 2017; 32: 152-61. doi: 10.3803/EnM.2017.32.2.152